IRIS
GROSA, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.454
EU - Europa 4.289
AS - Asia 2.153
SA - Sud America 284
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 55
OC - Oceania 1
Totale 11.345
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.333
RU - Federazione Russa 895
IE - Irlanda 764
CN - Cina 640
SG - Singapore 610
IT - Italia 551
SE - Svezia 535
DE - Germania 524
UA - Ucraina 359
HK - Hong Kong 295
VN - Vietnam 265
BR - Brasile 216
FI - Finlandia 216
FR - Francia 155
GB - Regno Unito 128
IN - India 116
CA - Canada 59
KR - Corea 49
TR - Turchia 36
BE - Belgio 33
IR - Iran 29
EE - Estonia 28
MX - Messico 27
AR - Argentina 26
BD - Bangladesh 21
CZ - Repubblica Ceca 18
ES - Italia 18
JP - Giappone 17
PL - Polonia 17
IQ - Iraq 15
ID - Indonesia 13
ZA - Sudafrica 12
EC - Ecuador 11
BJ - Benin 10
LT - Lituania 10
NL - Olanda 10
PK - Pakistan 10
EU - Europa 9
CL - Cile 8
MA - Marocco 8
CO - Colombia 6
HN - Honduras 6
PR - Porto Rico 6
NI - Nicaragua 5
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
AT - Austria 4
BG - Bulgaria 4
CH - Svizzera 4
EG - Egitto 4
PE - Perù 4
SA - Arabia Saudita 4
TH - Thailandia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
JM - Giamaica 3
MD - Moldavia 3
PH - Filippine 3
SV - El Salvador 3
TN - Tunisia 3
BO - Bolivia 2
BZ - Belize 2
CG - Congo 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GP - Guadalupe 2
GT - Guatemala 2
JO - Giordania 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
RO - Romania 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BW - Botswana 1
DM - Dominica 1
GA - Gabon 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
SX - ???statistics.table.value.countryCode.SX??? 1
TM - Turkmenistan 1
Totale 11.248
Salva come PNG Salva come JPEG
Città #
Dublin 764
Jacksonville 588
San Jose 371
Hong Kong 293
Dearborn 280
Chandler 261
Singapore 237
Ashburn 225
Beijing 224
Council Bluffs 198
Wilmington 156
Ann Arbor 147
Moscow 128
Piemonte 128
Los Angeles 105
Lawrence 100
Princeton 100
Lauterbourg 82
Ho Chi Minh City 81
San Mateo 81
Columbus 71
Andover 68
Munich 66
Hanoi 63
Buffalo 47
New York 47
Santa Clara 45
Seoul 45
Philadelphia 43
Woodbridge 39
Bremen 36
Helsinki 35
Milan 35
Boardman 32
Brussels 32
Houston 28
São Paulo 27
Hefei 24
Orem 24
Toronto 23
Dallas 21
Guangzhou 21
Frankfurt am Main 20
Nanjing 20
Chennai 19
Phoenix 18
Kocaeli 17
Rome 17
Brno 16
Brooklyn 16
Monmouth Junction 15
Denver 14
Redondo Beach 14
Tokyo 14
Brasília 13
Sacramento 13
Seattle 13
Warsaw 13
Hangzhou 12
Montreal 12
Tianjin 12
Norwalk 11
Torino 11
Atlanta 10
Chicago 10
Cotonou 10
Da Nang 10
Haiphong 10
Nanchang 10
Turku 10
Ankara 9
Boston 9
Jinan 9
London 9
Mexico City 9
Novara 9
Stockholm 9
Zhengzhou 9
Amsterdam 8
Dong Ket 8
Fairfield 8
Falkenstein 8
Johannesburg 8
Poplar 8
Shenyang 8
Zanjan 8
Ardabil 7
Biên Hòa 7
Chengdu 7
Kunming 7
Las Vegas 7
Leawood 7
Manchester 7
North Bergen 7
Nuremberg 7
Baghdad 6
Bari 6
Guarulhos 6
Mumbai 6
Naples 6
Totale 6.030
Salva come PNG Salva come JPEG
Nome #
ELEMENTI DI GALENICA CON ESERCIZI DI TARIFFAZIONE 220
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 188
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 187
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 183
Preparazioni galeniche Esercizi di tariffazione secondo la nuova TNM 181
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 174
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 174
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 171
Are 1,4- and 1,5-Disubstituted 1,2,3-Triazoles Good Pharmacophoric Groups? 167
A Concise Synthesis of Pyrazole Analogues of Combretastatin A1 as Potent Antitubulin Agents 165
Metabolic fate of combretastatin A-1: LC-DAD-MS/MS investigation and biological evaluation of its reactive metabolites 164
Development and validation of a stability-indicating HPLC-UV method for the determination of Thiocolchicoside and its degradation products 159
CHEMICAL STABILITY STUDIES OF PROPARGYLAMINE-CONTAINING DRUGS 155
Biological effects of combined resveratrol and vitamin D3 on ovarian tissue 154
La spettrometria di massa negli studi di stabilità dei farmaci 152
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs 148
New insights in the metabolism of oxybutynin: evidence of N-oxidation of propargylamine moiety and rearrangement to enaminoketone 146
New insights in oxybutynin chemical stability: Identification in transdermal patches of a new impurity arising from oxybutynin N-oxide rearrangement 145
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 144
DETERMINAZIONE HPLC SIMULTANEA DELLA GUAIFENESINA E DEL METILE E PROPILE p-IDROSSIBENZOATO IN UNA FORMULAZIONE LIQUIDA 138
Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues 138
Development and validation of a stability-indicating LC–UV method for the determination of pantethine and its degradation product based on a forced degradation study 136
Elementi di galenica con esercizi di tariffazione 136
FORCED DEGRADATION STUDY OF TIOCOLCHICOSIDE: HPLC-MS CHARACTERIZATION OF DEGRADATION PRODUCTS 135
CHEMICAL STABILITY STUDIES OF PROPARGYLAMINE CONTAINING-DRUGS 128
Development and validation of a stability-indicating HPLC-UV method for the determination of alizapride and its degradation products 125
A new approach in the synthesis of immunotoxins ribosome inactivating protein non covalently bound to monoclonal antibody 124
2,3-epoxy-10-aza-10,11-dihydrosqualene, an high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase 124
Troxerutin, a mixture of O-hydroxyethyl derivatives of the natural flavonoid rutin: Chemical stability and analytical aspects 124
Azasqualene alcohol and derivatives new selective inhibitors of 2,3-oxidosqualene cyclase 120
2,3,4,5-tetrahydroxy-5- (4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling 120
Development and validation of a solid-phase extraction and gas chromatography–tandem mass spectrometry method for the determination of isopropyl-9H-thioxanthen-9-one in carton packaged milk 120
Synthesis and antibronchospastic activity of theophylline thioacetal derivatives 118
FORCED DEGRADATION STUDY OF DOXOFYLLINE: HPLC-MS CHARACTERIZATION OF DEGRADATION PRODUCTS IN BULK DRUG 118
DEVELOPMENT AND VALIDATION OF HPLC-UV STABILITY INDICATING METHOD FOR THE DETERMINATION OF THIOCOLCHICOSIDE AND ITS DEGRADATION PRODUCTS IN PHARMACEUTICAL DOSAGE FORM 118
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis 118
3-carboxy-4-nitrophenyl-dithio-1,1',2-trisnorsqualene: a site-directed inactivator of yeast oxidosqualene cyclase 117
Synthesis of a squalenoid oxaziridine and other new classes of squalene derivatives, as inhibitors of sterol biosynthesis 115
Semicarbazide Hydrochloride as Impurity in Drug Substances: a Validated LC-DAD-UV Method for Its Determination in Carbazochrome and Carbazochrome Sodium Sulfonate 115
New Hyaluronic Acid from Plant Origin to Improve Joint Protection—An In Vitro Study 113
2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors 111
In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study 110
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 110
IN VITRO METABOLISM STUDY OF ISOPROPYL-9H-THIOXANTHEN-9-ONE (ITX) IN RAT LIVER MICROSOMES 110
In vitro metabolism of Bumetanide 109
An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline 108
Forced degradation study of thiocolchicoside: Characterization of its degradation products 108
FORCED DEGRADATION OF DOXOFYLLINE IN BULK DRUG: IDENTIFICATION OF THREE DEGRADATION PRODUCTS 108
Thiol-modifying inhibitors for understanding squalene cyclase function 107
LC-ESI-MS/MS CHARACTERIZATION OF DEGRADATION PRODUCTS OF TROPANE ALKALOIDS IN BELLADONNA DRY EXTRACT 106
Metabolic Fate of the Isocyanide Moiety: Are Isocyanides Pharmacophore Groups Neglected by Medicinal Chemists? 104
Kinetics of ABC-99 in the rat 102
Drug design based on biosynthetic studies: synthesis, biological activity and kinetics of new inhibitors of 2,3-oxido squalene cyclase and squalene epoxidase 102
Doxofylline in rat brain in relation to locomotor activity - Drug Metabolism and Disposition 102
In vitro metabolism study of 2-isopropyl-9H-thioxanthen-9-one (2-ITX) in rat and human: evidence for the formation of an epoxide metabolite 101
Role of chocolate consumption in the inflammatory pathway: a proteomic approach 101
A new "solid phase" procedure to synthetize immunotoxins 100
In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes 100
2-aza-2,3-dihydrosqualene:biodistribution and pharmacokinetic properties in mice 99
IN VITRO METABOLIC FATE OF COMBRETASTATIN A-4: EVIDENCE FOR THE FORMATION OF A SULPHATE CONJUGATE METABOLITE 99
SIMULTANEOUS DETERMINATION OF SEROTONIN AND CATECHOLAMINES IN RAT BRAIN BY LC-MS/MS 95
FORCED DEGRADATION STUDY OF OXYBUTYNIN: NEW INSIGHTS FROM LC-MS/MS ANALYSIS ON ITS CHEMICAL STABILITY 94
LC-MS CHARACTERIZATION OF THE IN VITRO METABOLITES OF ALIZAPRIDE 93
IN VITRO, IN VIVO METABOLISM STUDY OF COMBRETASTATIN A-4 IN RAT AND HUMAN 93
Synthesis and biological activity of 19-azasqualene 2,3-epoxide as inhibitor of 2,3-oxidosqualene cyclase 92
In vitro metabolic fate of alizapride: evidence for the formation of reactive metabolites based on liquid chromatography-tandem mass spectrometry 92
In vitro metabolism of 2-(5-ethylpyridin-2-yl)benzimidazole 92
IN VITRO METABOLISM OF ALIZAPRIDE: EVIDENCE FOR THE FORMATION OF ACROLEIN IN RAT LIVER MICROSOMES 91
Metabolism of Doxophylline by rat liver microsomes 91
Synthesis of squalenoid acetylenes and allenes, as inhibitors of squalene epoxidase 90
Synthesis and biological activity of a squalenoid maleimide and other classes of squalene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase 89
Nitroanilines are the reduction products of benzofuroxan system by oxyhemoglobin (HbO22+) 89
HPLC DETERMINATION OF DOXOFYLLINE AND ITS DEGRADATION PRODUCTS IN DRUG SUBSTANCE: DEVELOPMENT AND VALIDATION 88
Metabolism of 4-(3-cyclohexylpropionyl)-1-(2-ethoxyphenyl)piperazine (D-16120) by rat liver microsomes 87
Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4. Drug Metabolism and Disposition 87
In vitro metabolism of N-picolyl-3,5-dimethylbenzamides 86
Toxin-targeted design for anticancer therapy - Part I. Synthesis and biological evaluation of new thioimidate heterobifunctional reagents 86
Solubilization and identification of essential functional groups of Candida albicans oxidosqualene cyclase 85
In vitro metabolism of azasqualene derivatives and their effects on aminopyrine N-demethylase activity in rat liver microsomes 85
LC-ESI-MS/MS characterization of strophanthin-K 84
In vitro metabolism study of 2-isopropyl-9H-thioxanthen-9-one (2-ITX) in rat and human: Evidence for the formation of an epoxide metabolite 84
The Metabolic Fate of isoCombretastatin A-4 in Human Liver Microsomes: Identification, Synthesis and Biological Evaluation of Metabolites. 83
IN VITRO METABOLIC FATE OF COMBRETASTATIN A-4: EVIDENCE FOR THE FORMATION OF QUINONE METABOLITES 83
Metabolism of 1,1-dichloro-cis-diphenylcyclopropane by rat liver microsomes 82
Metabolismo in vitro della 7-(3-acetil-1,3-tiazolidin-2-ilmetil)teofillina: solfossidazione diastereoselettiva 80
Pharmacokinetic of an antibody-ricin conjugate administered intraperitoneally to mice 80
Thermolysis of 4-(2-azido-3-nitrophenyl)-1,4-dihydropyridines as sources of b-carboline derivatives and some related compounds 80
Formation of lecithin-based microemulsions containing n-alkanol phosphocholines 80
In vitro and in vivo phase II metabolism of combretastatin A-4: evidence for the formation of a sulphate conjugate metabolite 80
The metabolic fate of the anti-Parkinsonian drug Budipine in rats 79
NO-Donor 1,4-dihydropyridine analogues of Amlodipine 79
LC-MS CHARACTERIZATION OF IN VITRO METABOLISM OF COMBRETASTATIN A-4 77
Simultaneous, stability indicating, HPLC-DAD determination of guaifenesin and methyl and propyl-parabens in cough syrup 77
Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes: evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage 77
Lack of in vitro interactions using human liver microsomes between rabeprazole and anticancer drugs 75
LC-MS CHARACTERIZATION OF K-STROPHANTHIN 74
LC-MS ANALYSIS OF BITTER PRINCIPLES OF ARTEMISIA ABSINTHIUM L 74
Metabolism of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine (ABC-99) by rat liver microsomes: diastereoselective metabolism of the 1,3-dithiolane ring 73
In vivo metabolism of the anti-inflammatory agent 2-(5-ethyl-pyridin-2-yl)benzimidazole (KB-1043) 72
IN VITRO METABOLISM STUDY OF ISOPROPYL-9H-THIOXANTHEN-9-ONE (ITX) IN RAT AND HUMAN LIVER MICROSOMES 69
Totale 11.221
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.720
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022678 0 0 0 144 46 5 79 20 50 65 91 178
2022/20231.713 114 53 80 71 145 187 48 110 794 8 56 47
2023/2024431 47 33 34 7 78 3 98 14 0 14 36 67
2024/20251.038 33 20 43 24 40 90 133 54 276 118 31 176
2025/20263.522 165 119 259 515 341 270 474 614 226 312 174 53
2026/2027830 154 272 158 246 0 0 0 0 0 0 0 0
Totale 11.345